Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Supernus Pharmaceuticals Prices Its IPO In The Range Of $12-$14 Per Share

Supernus Pharmaceuticals Wednesday announced that it has filed Form S-1 with the Securities and Exchange Commission or the SEC revealing the pricing of its initial public offering for 5,769,000 shares of common stock.

The company revealed that it anticipates to price the initial public offering to be between $12.00 and $14.00 per share of common stock.

The company further added that it has granted the underwriters an option to purchase up to 865,350 additional shares of common stock to cover over-allotments.

The company stated that itsd shares would be listed on the Nasdaq Global Market under the symbol "SUPN."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Firms responding to a survey by the Federal Reserve Bank of Philadelphia indicated continued growth in regional manufacturing activity in September, although the bank said the index of activity in the sector fell from its relatively high reading in August. Stocks have moved mostly higher in early trading on Thursday, extending a recent upward move by the markets. The major averages have all climbed into positive territory, with the Dow reaching a new record intraday high. With new construction of multi-family homes showing a substantial pullback, the Commerce Department released a report on Thursday showing a much steeper than expected drop in U.S. housing starts in the month of August.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.